Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update evaluating DR-3001 for efficacy and safety in women with overactive bladder. The study, sponsored by Duramed Research, h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• DR-3001

Snippet

Sponsor: Duramed Research | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED